Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Mak, Susanna ^a   Newton, Gary E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Antioxidants; Contractility; Receptors; adrenergic

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG RESPONSE; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE CONTRACTILITY; HUMAN; INOTROPISM; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REDUCTION;

EID: 0942265667     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00633.2003     Document Type: Article

References (58)

1. Berger TM, Polidori MC, Dabbagh A, Evans PJ, Halliwell B, Morrow JD, Roberts LJ, and Frei B. Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 272: 15656-15660, 1997.
2. Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, and Feldman AM. β-Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 82: 112-125, 1990.
3. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, and Karwande SV. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89: 803-815, 1992.
4. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, and Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104: 2407-2411, 2001.
5. Carr A and Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 13: 1007-1024, 1999.
6. Dhalla AK, Hill MF, and Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28: 506-514, 1996.
7. Diaz-Velez DR, Garcia-Castineiras G, Mendoza-Ramos E, and Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 131: 146-152, 1996.
8. Drexler H. Nitric oxide synthases in the failing human heart: a doubled-edged sword? Circulation 99: 2972-2975, 1999.
9. Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, Kass DA, Marban E, and Hare JM. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res 85: 437-445, 1999.
10. Frei B, England L, and Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377-6381, 1989.
11. Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, Balligand JL, and Le MH. The negative inotropic effect of β-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102: 1377-1384, 1998.
12. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo? Free Radic Res 25: 439-454, 1996.
13. Hare JM, Givertz MM, Creager MA, and Colucci WS. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure. Potentiation of β-adrenergic inotropic responsiveness. Circulation 97: 161-166, 1998.
14. Hare JM, Loh E, Creager MA, and Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92: 2198-2203, 1995.
15. Hare JM, Lofthouse RA, Juang GJ, Colman L, Ricker KM, Kim B, Senzaki H, Cao S, Tunin RS, and Kass DA. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ Res 86: 1085-1092, 2000.
16. Hayashi Y, Takeuchi M, Takaoka H, Hata K, Mori M, and Yokoyama M. Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction: increased oxygen cost of contractility. Circulation 93: 932-939, 1996.
17. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, and Werner ER. L-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276: 40-47, 2001.
18. Hill MF and Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96: 2414-2420, 1997.
19. Huie RE and Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199, 1993.
20. Jackson TS, Xu A, Vita JA, and Keaney JF. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83: 916-922, 1998.
21. Kaneko M, Chapman DC, Ganguly PK, Beamish RE, and Dhalla NS. Modification of cardiac adrenergic receptors by oxygen free radicals. Am J Physiol Heart Circ Physiol 260: H821-H826, 1991.
22. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, and Jeejeebhoy KN. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31: 1352-1356, 1998.
23. Levine M, Daruwala RC, Park JB, Rumsey SC, and Wang Y. Does vitamin C have a pro-oxidant effect? Nature 395: 231, 1998.
24. Liang C, Rounds NK, Dong E, Stevens SY, Shite J, and Qin F. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial beta-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins. Circulation 102: 96-103, 2000.
25. Lunec J and Blake D. Oxygen free radicals: their relevance to disease processes. In: The Metabolic and Molecular Basis of Acquired Disease, edited by Cohen RD, Lewis B. Alberti KGMM, and Denman AM. London: Bailliere Tindall, 1990, p. 189-212.
26. Mak S, Lehotay DC, Yazdanpanah M, Azevedo ER, Liu PP, and Newton GE. Unsaturated aldehydes including 4-OH-nonenal are elevated in patients with congestive heart failure. J Card Fail 6: 108-114, 2000.
27. Mak S and Newton GE. Vitamin C augments the inotropic response to dobutamine in humans with normal left ventricular function. Circulation 103: 826-830, 2001.
28. May JM. How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 28: 1421-1429, 2000.
29. Mayer B and Andrew P. Nitric oxide synthases: catalytic function and progress towards selective inhibition. Arch Pharm (Weinheim) 358: 127-133, 1998.
30. McArdle A, Pattwell D, Vasilaki A, Griffiths RD, and Jackson MJ. Contractile activity-induced oxidative stress: cellular origin and adaptive responses. Am J Physiol Cell Physiol 280: C621-C627, 2001.
31. McMurray J, Chopra M, Abdullah I, Smith WE, and Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 14: 1493-1498, 1993.
32. Newton GE, Parker AB, Landzberg JS, Colucci WS, and Parker JD. Muscarinic receptor modulation of basal and β-adrenergic stimulated function of the failing human left ventricle. J Clin Invest 98: 2756-2763, 1996.
33. Patel MB, Kaplan IV, Patni RN, Levy D, Strom JA, Shirani J, and LeJemtel TH. Sustained improvement in flow-mediated vasodilation after short-term administration of dobutamine in patients with severe congestive heart failure. Circulation 99: 60-64, 1999.
34. 2+-sensitizing property of xanthine oxidase inhibitors. Circ Res 83: 423-430, 1998.
35. 2 in changing β-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol Cell Biochem 186: 99-106, 1998.
36. 2. Am J Physiol Heart Circ Physiol 274: H416-H423, 1998.
37. Persad S, Takeda S, Panza JA, and Dhalla NS. β-Adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals. J Mol Cell Cardiol 29: 545-558, 1997.
38. Persad S, Elimban V, Siddiqui F, and Dhalla NS. Alterations in cardiac membrane β-adrenoceptors and adenylyl cyclase due to hypochlorous acid. J Mol Cell Cardiol 31: 101-111, 1999.
39. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, and Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 392: 559, 1998.
40. Port JD and Bristow MR. Altered β-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol 33: 887-905, 2001.
41. Poulsen HE, Weimann A, Salonen JT, Nyyssonen K, Loft S, Cadet J, Douki T, and Ravanat JL. Does vitamin C have a pro-oxidant effect? Nature 395: 231-232, 1998.
42. Proteggente AR, England TG, Rice-Evans CA, and Halliwell B. Iron supplementation and oxidative damage to DNA in healthy individuals with high plasma ascorbate. Biochem Biophys Res Commun 288: 245-251, 2001.
43. Proteggente AR, Rehman A, Halliwell B, and Rice-Evans CA. Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo? Biochem Biophys Res Commun 277: 535-540, 2000.
44. Reid MB. Nitric oxide, reactive oxygen species, and skeletal muscle contraction. Med Sci Sports Exerc 33: 371-376, 2001.
45. Reid MB, Haack KE, Franchek KM, Valberg PA, Kobzik L, and West MS. Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol 73: 1797-1804, 1992.
46. Reid MB, Shoji T, Moody MR, and Entman ML. Reactive oxygen in skeletal muscle. II. Extracellular release of free radicals. J Appl Physiol 73: 1805-1809, 1992.
47. Saavedra WF, Paolocci N, St JM, Skaf MW, Stewart GC, Xie JS, Harrison RW, Zeichner J, Mudrick D, Marban E, Kass DA, and Hare JM. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 90: 297-304, 2002.
48. Samuni A, Aronovitch J, Godinger D, Chevion M, and Czapski G. On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur J Biochem 137: 119-124, 1983.
49. Sherman DL, Keaney JF, Biegelson ES, Duffy SJ, Coffman JD, and Vita JA. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35: 936-941, 2000.
50. Shinke T, Takaoka H, Takeuchi M, Hata K, Kawai H, Okubo H, Kijima Y, Murata T, and Yokoyama M. Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to β-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy. Circulation 101: 1925-1930, 2000.
51. Singal PK, Kapur N, Khillon KS, Beamish RE, and Dhalla NS. Role of free radcals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 60: 1390-1397, 1981.
52. Siveski-Iliskovic N, Kaul N, and Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 89: 2829-2835, 1994.
53. Stofan DA, Callahan LA, DiMarco AF, Nethery DE, and Supinski GS. Modulation of release of reactive oxygen species by the contracting diaphragm. Am J Respir Crit Care Med 161: 891-898, 2000.
54. Suh J, Zhu BZ, and Frei B. Ascorbate does not act as a pro-oxidant towards lipids and proteins in human plasma exposed to redox-active transition metal ions and hydrogen peroxide. Free Radic Biol Med 34: 1306-1314, 2003.
55. Supinski G, Nethery D, Stofan D, and DiMarco A. Extracellular calcium modulates generation of reactive oxygen species by the contracting diaphragm. J Appl Physiol 87: 2177-2185, 1999.
56. Udenfriend S, Clark CT, Axelrod J, and Brodie B. Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. J Biol Chem 208, 731-739. 1954.
57. Ukai T, Cheng CP, Tachibana H, Igawa A, Zhang ZS, Cheng HJ, and Little WC. Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure. Circulation 103: 750-755, 2001.
58. Vatner DE, Kiuchi K, Manders WT, and Vatner SF. Effects of coronary arterial reperfusion on β-adrenergic receptor-adenylyl cyclase coupling. Am J Physiol Heart Circ Physiol 264: H196-H204, 1993.